Why is Disrupting Clinical Operations With CRO Strategic Partnerships Important?

Due to increasing globalization and regulatory complexity, the use of outsourcing models using Contract Research Organizations or CROs in different phases of clinical research is trending.

 

The primary reason behind this trendsetting is the benefits to be gained from the external specializations that will allow the drug makers to focus on their core competencies.

Outsourcing models have always been considered as the key to sustained mutual growth, however, how it will innovate the industry was still unclear until the discovery of the cloud.

With cloud-based software, it became possible to revolutionize the traditional clinical trial workflow.

As per the experts, choosing an appropriate CRO is an important task and there are certain characteristics to look for before making a decision.

The characteristics to look for in a CRO are its readiness to embrace new technologies, expertise in risk-based monitoring, specialization in data management services, and strong relationships with sites and local regulatory agencies.

 

3 Key Points

  1. Embracement of cloud-based solutions using CROs has changed the way of connecting and sharing information.
  2. The use of cloud-based software has entirely revolutionized the conventional clinical trial workflow.
  3. Relationships, qualifications, and subject matter expertise are certain factors to look for during CRO selection but are currently not considered as sufficient criteria.

“The trend of biopharma companies and CROs developing their technology strategies and roadmaps independently has resulted in an enterprise information portfolio that is made up of various disparate data warehouse and storage areas. This disconnected approach is magnified when clients that work with multiple CROs receive both patient and operation data/reports in each of their partners’ formats, causing clients to manage their studies or programs through these non-standardized processes.” – David Blackman,  Business Innovation Director at Pharmaceutical Product Development

Source: https://www.clinicalleader.com/doc/disrupting-clinical-operations-with-cro-strategic-partnerships-0003

#ClinicalResearch, #ClinicalTrial, #ElectronicDataCapture

P.S. Want to stay up to date with how CRO is changing clinical trials? Get the latest articles summarized and delivered free to your e-mail inbox. Click here to learn more.

Latest news

ACTide by Nubilaria against COVID-19

DECEIVER trial for COVID-19 related ARDS intensive care

Read more
Nubilaria ACTide @ Medical device trials

Medical Device Trials – Virtual Experience

Read more
Nubilaria ACTide @ Direct to Patient digital experience

Direct-to-Patient and Virtual Clinical Trials – Digital Experience

Read more

Want more information about our solutions?
Contact us today.

I've read and accept theTerms and Conditions and the Privacy Policy
   I would like to receive information about products and services via traditional mail, telephone, email and automated communication systems